Microsoft Co-Founder Bill Gates Backs Satya Nadella, Brad Smith Amid Ongoing Federal Investigation Over Security Concerns: ‘…Doing A Great Job There’
Gates currently serves the company as an advisor.
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer
AstraZeneca's breakthrough drug, Imfinzi, combined with chemotherapy, has been officially approved by the FDA to treat advanced forms of endometrial cancer with mismatch repair deficiency. This critical approval is based on Phase III trial results showing a 58% reduction in disease progression, promising improved outcomes for those battling this severe cancer.
Adidas Faces Bribery Allegations In China, Launches Investigation: Report
Adidas AG is reportedly probing deep into accusations of bribery within its China operations, following whistleblower allegations of high-ranking officials embezzling millions. Despite the severity, no staff have been suspended as Adidas reassures its commitment to high ethical standards.
AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer
AstraZeneca shares data from the ECHO Phase 3 trial on Calquence plus bendamustine and rituximab in untreated mantle cell lymphoma patients over 65.
EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says
Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.
EXCLUSIVE: ‘Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,’ Petros Pharma President Says
Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5 billion Rx-to-OTC market projected by 2033.
Tim Cook Tells MKBHD Blindly Ranking Apple Products Is Like Choosing ‘Your Favorite Nieces Or Nephews:’ This Is What Cupertino Chief Thinks About MacBook, iPad, iPhone, Magic Mouse And Vision Pro
The Apple CEO was asked to rank each Apple product without knowing the rest of the products.
Apple’s AI Endeavors, iOS 18, And A Spat With Elon Musk: This Week In Appleverse
Tech news: Apple's AI-powered features, iOS 18 update, OpenAI partnership and Steve Wozniak's take on AI. Elon Musk criticizes partnership.
Tesla’s Top Rival BYD Unveils Latest EV Model Under Fang Cheng Bao Lineup: Report
BYD's Fang Cheng Bao debuts Bao 3, labeled as the production version of the Super 3 concept, featuring nine images showcasing its electric prowess.
Huntington Bancshares Underperforming Relative To Peers, Analyst Downgrades Stock
Huntington Bancshares faces downgrade as analyst cites underperformance, projecting challenges ahead amid adjusted earnings outlook.